Pharma News

Eli Lilly forged a multi-year collaborative partnership with China-based Regor Therapeutics Group to discover and develop new therapies for metabolic disorders.  ...

Aprea Therapeutics has received FDA clearance to continue its eprenetapopt development, with the lifting of a full clinical hold placed last summer on the drug’s nonHodgkin’s lymphoma clinical ...

The share price of Arena Pharmaceuticals nearly doubled in premarket trading after pharma giant Pfizer announced it was acquiring the company and its diverse portfolio of developmental and clinical...

A panel of FDA advisers voted unanimously, 13 to 0, that Reata Pharmaceuticals' chronic kidney disease (CKD) med was not effective.

Sonodynamic therapy uses ultrasound in combination with drugs to release harmful reactive oxygen species (ROS) at the site of a tumor. 

Heron Therapeutics, Inc., a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet pati...

Ionis Pharmaceuticals, based in Carlsbad, Calif., inked a collaboration deal with AstraZeneca to develop and commercialize eplontersen for transthyretin amyloidosis (ATTR). ...

Singapore has attracted a slate of vaccine heavyweights in recent years. 

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for the pre...

It’s been more than a decade since Dendreon’s prostate cancer immunotherapy, Provenge, won FDA approval. 

Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.

A new drug application (NDA) seeking the approval of poziotinib as a potential therapeutic option for patients with previously treated locally advanced or metastatic non–small cell lung cancer (...